Fiche publication


Date publication

août 2000

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr WESTEEL Virginie


Tous les auteurs :
Andre F, Grunenwald D, Pignon JP, Dujon A, Pujol JL, Brichon PY, Brouchet L, Quoix E, Westeel V, Le Chevalier T

Résumé

Patients who suffer from non-small-cell lung cancer (NSCLC) with ipsilateral mediastinal lymph node involvement (N2) belong to a heterogeneous subgroup of patients. We analyzed the prognosis of patients with resected N2 NSCLC to propose homogeneous patient subgroups.

Mots clés

Adolescent, Adult, Aged, Aged, 80 and over, Analysis of Variance, Carcinoma, Non-Small-Cell Lung, classification, Chemotherapy, Adjuvant, Female, Humans, Lung Neoplasms, classification, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Preoperative Care, Prognosis, Proportional Hazards Models, Retrospective Studies, Survival Analysis, Survival Rate

Référence

J. Clin. Oncol.. 2000 Aug;18(16):2981-9